期刊文献+

住院精神分裂症患者伴发代谢综合征的调查分析 被引量:7

Investigation of prevalence of metabolic syndrome in hospitalized patients with schizophrenia
原文传递
导出
摘要 目的调查住院精神分裂症患者代谢综合征的发生率,分析与代谢综合征有关的危险因素。方法以2008年1月—12月郑州市第八人民医院符合CCMD-3诊断标准的精神分裂症患者出院病例为研究对象,代谢综合征的诊断标准采用2004年医学会糖尿病分会代谢综合症标准。了解精神分裂症患者代谢综合症的发生率,用Logistic回归分析影响发生的相关因素。结果符合条件共入组完成726例,精神分裂症患者中代谢综合征患病率32.3%。代谢综合征患病相关的危险因素有年龄、氯氮平及精神分裂症的病程(P<0.05)。Logistis回归分析结果显示,精神分裂症患者伴发代谢综合症的危险因素是高龄,病程。结论与普通人群相比,精神分裂症患者具有较高的代谢综合症患病风险,可能的危险因素有高龄,病程长和服用氯氮平等。 Objective To evaluate the prevalence of metabolic syndrome (MS) in schizophrenics and explore the relative factors. Methods We conducted a cross - sectional study of schizophrenics from inpatients in the eighth people' s hospital of Zhengzhou in 2008. The diagnosis of MS was estab- lished with the criteria of branch of diabetes mellitus of Chinese Medical Association. Results Among 726 schizophrenic, there were 235 cases(32.3% ) suffered from metabolic syndrome. Single -factor analysis showed that age, duration of the disease, the classification of antipsychotics(clozapine) , were at high risk of metabolic syndrome. Logistic regression analysis appeared that metabolic syndrome correlated with age duration of the disease. Conclusions The metabolic syndrome is highly prevalent among patients with schizophrenia and is strongly associated with age, longer duration of schizophrenia and clozapine.
出处 《医药论坛杂志》 2011年第11期35-37,共3页 Journal of Medical Forum
关键词 精神分裂症 代谢综合症 抗精神病药 Schizophrenia Metabolic syndrome Antipsychotics
  • 相关文献

参考文献10

  • 1Miller DD. Reviw and management of clozapine sideeffects[ J ]. J Clin Psychiatry, 2000,61 ( suppl 8 ) : 14- 17. 被引量:1
  • 2Osby U, Correia N, Brandt L, et al. Time trends in schizophrenia in stockholm County, Sweden cohole study [ J ]. BMJ, 2000,321 ( 7259 ) :483-484. 被引量:1
  • 3Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome[ J]. Diabetes Care,2001,24(4) :683-689. 被引量:1
  • 4McEvoy JP, Meyer JM, Goff DC, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness ( CATIE ) schizophrenia trial and comparison with national estimates from NHANES Ⅲ [ J ]. Schizophr Res ,2005,80 ( 1 ) :19-32. 被引量:1
  • 5De Hert M, van Winkel R, Van Eyck D, et al. Preva- lence of diabetes, metabolic syndrome and metabolic abnormalites in schizophrenia over the course of the illness : a crosssectional study [ J ]. Clin Pract Epidemol Ment Health ,2006,2 : 14. 被引量:1
  • 6陈蕾,贾伟平,陆俊茜,包玉倩,吴元民,姜素英,项坤三.上海市成人代谢综合征流行调查[J].中华心血管病杂志,2003,31(12):909-912. 被引量:336
  • 7Gianfrancesco FD, Grogg AL, Mahmoud RA, et al. Differentional effects of risperidone, olanzapine, cloza- pine and conventional antipsychotics on type 2 diabe- tes: findings from a large health plan database [ M ]. Year Book Of Psychiatry & Applied Mental Health, 2004 : 343-344. 被引量:1
  • 8Conhen D. Diabetes mellitus during olanzapine and quetiapine treatment in Japan [ J]. J Clin Psychiatry, 2005,66(2) :265-266. 被引量:1
  • 9Allison DB,Mentore JL,Heo M, et al. Antipsyehotie - indueed weight gain: a comprehensive researeh synthesis[J]. Am J Psychiatry,1999, 156 ( 11 ) :1686-1696. 被引量:1
  • 10Keek PE Jr, McElory SL. Aripiprazole: a partial dopa- mine D2 reeeptor agonist antipsyehotic [ J ]. Expert Opin Investig Drugs, 2003,12 ( 3 ) : 655-662. 被引量:1

共引文献335

同被引文献81

  • 1何耀,封康,王洁,常青,姜勇,范利,李小鹰.老年人群代谢综合征的患病率及其与心脑血管病的关系[J].中华老年心脑血管病杂志,2006,8(9):597-600. 被引量:22
  • 2沈渔邨.精神病学[M].5版.北京:人民卫生出版社.2009:838. 被引量:249
  • 3方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 4McEvoy JP,Meyer JM,Goff DC,et al. Prevalence of themetabolic syn-drome in patients with schizophrenia:baseline results from the Clinical Antipsyehotic Trialsof Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES [J]. Schizophrenia, 2005,80( 1 ) : 19-32. 被引量:1
  • 5De Hert M,Van Winkel R,Van Eyck D,et al. Prevalence of diabetes, metabolic syndrome and metabolic abnormalites in schizophrenia over the course of the illness across-sectional study [J]. ClinPract Epidemol Ment Health,2006,2: 14. 被引量:1
  • 6Con'ell CU, Frederickson AM, Kane J,et al. M etabolicsyndrome and the risk of coronary heart disease in 367 patients treated with second - generation antipsychotic drugs [J]. J C linPsychiat,2006,67(4):575-583. 被引量:1
  • 7Gianfrancesco FD, Grogg AL, Mahmoud RA,et al. Differentional effects of risperidone,olanzapine,clozapine and conventional antipsychoticson type 2 diabetes:findings from a large health plan: database [J]. Year Book of Psychiatry&Applied Mental Health, 2004 : 343- 344. 被引量:1
  • 8Conhen,D. Diabetes mellitus during olanzapine and quetiapine treat- ment in Japan [J]. J Clin Psychiatry, 2005,66 (2) :265-266. 被引量:1
  • 9Allison DB,Mentore JL,Heo M,et al. Antipsychotic-induced weight gain: a comprehensive research synthesis [J]. Am J Psychiatry, 1999, 156( 11 ) : 1686-1696. 被引量:1
  • 10Keck PE Jr, McElory SL. Aripiprazole:a partial dopamine D2 receptor- agonist antipsychotic [J]. Expert OpinInvestig Drugs, 2003,12 (3) : 655 - 662. 被引量:1

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部